Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation. [electronic resource]
Producer: 20190314Description: 341-346 p. digitalISSN:- 1572-8595
- Aged
- Anticoagulants -- administration & dosage
- Atrial Fibrillation -- drug therapy
- Catheter Ablation -- adverse effects
- Cohort Studies
- Factor Xa Inhibitors -- administration & dosage
- Female
- Hemorrhage -- chemically induced
- Humans
- Male
- Middle Aged
- Netherlands -- epidemiology
- Outcome and Process Assessment, Health Care
- Postoperative Complications -- epidemiology
- Retrospective Studies
- Thromboembolism -- epidemiology
- Vitamin K -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.